Cargando…
High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
Autores principales: | Mor-Vaknin, Nirit, Rivas, Miguel, Legendre, Maureen, Yuanfang, Y, Johnson, Anne, Huang, Bin, Kimura, Yuki, Zhao, Lili, Spalding, Steve, Morris, Paula, Gottlieb, Beth, Onel, Karen, Olson, Judyann, Edelheit, Barbara, Shishov, Michael, Jung, Larry, Cassidy, Elaine, Prahalad, Sampath, Passo, Murray, Beukelman, Timothy, Mehta, Jay, Schmidt, Kara, Giannini, Ed, Lovell, Daniel, Markovitz, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822200/ http://dx.doi.org/10.1186/1546-0096-12-S1-P8 |
Ejemplares similares
-
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
por: Mor‐Vaknin, Nirit, et al.
Publicado: (2018) -
DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling
por: Capitano, Maegan L., et al.
Publicado: (2022) -
Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014) -
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2017) -
The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)